vTv Therapeutics Inc. (VTVT) Form 8-K Material Events
vTv Therapeutics Inc. (VTVT) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: VTVT
CIK: 1641489
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerMarc Carlson
Audit LocationDetroit, Michigan, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | 2026-10-08 | — | SCHEDULE 13G/A Filing | 0001104659-26-114761 | View SEC Doc Filr Page |
| 8-K | 2026-10-06 | 2026-10-01 | 8-K | 0001641489-26-000032 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001641489-26-000030 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | 8-K | 0001641489-26-000029 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-29 | — | SCHEDULE 13G/A Filing | 0001104659-26-088300 | View SEC Doc Filr Page |
| 4 | 2026-06-29 | 2026-06-26 | 4 | 0001193125-26-288602 | View SEC Doc Filr Page |
| 8-K | 2026-06-29 | 2026-06-26 | 8-K | 0001641489-26-000024 | View SEC Doc Filr Page |
| 4 | 2026-06-29 | 2026-06-26 | FORM 4 | 0001238403-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-06-29 | 2026-06-26 | FORM 4 | 0001253170-26-000008 | View SEC Doc Filr Page |
| 4 | 2026-06-29 | 2026-06-26 | FORM 4 | 0001928247-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-06-29 | 2026-06-26 | FORM 4 | 0001627680-26-000006 | View SEC Doc Filr Page |
| DEFA14A | 2026-06-10 | — | DEFA14A | 0001193125-26-265834 | View SEC Doc Filr Page |
| 424B2 | 2026-05-13 | — | 424B2 | 0001193125-26-221975 | View SEC Doc Filr Page |
| 8-K | 2026-05-13 | 2026-05-13 | 8-K | 0001193125-26-221971 | View SEC Doc Filr Page |
| S-8 | 2026-05-13 | — | S-8 | 0001193125-26-221965 | View SEC Doc Filr Page |
| 10-Q | 2026-05-13 | 2026-03-31 | 10-Q | 0001641489-26-000020 | View SEC Doc Filr Page |
| 8-K | 2026-05-13 | 2026-05-13 | 8-K | 0001641489-26-000019 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-28 | 2026-06-10 | DEF 14A | 0001641489-26-000015 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-04-16 | — | SCHEDULE 13G/A Filing | 0001104659-26-044451 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-03-27 | — | SCHEDULE 13G Filing | 0001104659-26-036184 | View SEC Doc Filr Page |
| 8-K | 2026-03-10 | 2026-03-10 | 8-K | 0001641489-26-000012 | View SEC Doc Filr Page |
| 8-K | 2026-03-10 | 2026-03-10 | 8-K | 0001641489-26-000011 | View SEC Doc Filr Page |
| 10-K | 2026-03-10 | 2025-12-31 | 10-K | 0001641489-26-000010 | View SEC Doc Filr Page |
| 8-K | 2026-02-26 | 2026-02-26 | 8-K | 0001641489-26-000005 | View SEC Doc Filr Page |
| 4 | 2026-02-18 | 2026-02-17 | FORM 4 | 0002069755-26-000003 | View SEC Doc Filr Page |